46 results on '"Wieczorek Ł"'
Search Results
2. More than recycling – The potential of the circular economy shown by a case study of the metal working industry
3. A Miniature DC-SQUID Magnetometer with Current Injection Feedback
4. Bedeutung der Gentechnik für die Diagnostik
5. Oral ibandronate: changes in markers of bone turnover during adequately dosed continuous and weekly therapy and during different suboptimally dosed treatment regimens
6. Morphology and optical properties of gold thin films prepared by filtered arc deposition
7. Nebenwirkungen der Therapie der renalen Anämie mit rekombinantem humanem Erythropoietin
8. Erste Erfahrungen bei der Behandlung terminal niereninsuffizienter Kinder mit rhEPO
9. Molekulare Biologie von Erythropoietin
10. Empfindlichkeitsprüfung mit dem Micur®-Testsystem
11. Thermal Conductivity of Amorphous Films
12. Erythropoietin in Renal and Non-Renal Anemias : Update on Basic Research and Clinical Applications.. 3rd International Workshop on Treatment of Anemia with Recombinant Human Erythropoietin, Telfs-Buchen, June 1990
13. Erythropoietin: From Molecular Structure to Clinical Application : International Workshop, Cologne, March 1989
14. Legal and social implications of sexual services other than prostitution
15. Influence des missions d'exception sur le développement des capacités de gestion du stress chez les intervenants médicaux
16. Exposition des intervenants paramédicaux à des événements catastrophiques : conséquences psychiques
17. C003 A molecular classification of leukaemia reveals MDS as a disease continuum with non-leukaemia and AML sub groups
18. Soluble and bacteriophage T4 displayed gp41 mutant proteins as HIV-1 vaccine candidates
19. Cross-clade neutralization of HIV-1 by a monoclonal antibody obtained by immunization with liposomes containing lipid A and a synthetic MPER peptide
20. The impact of differences in viral entry and trafficking on the mechanism of HIV-1 neutralization
21. Antigenicity and immunogenicity of a novel, acute HIV-1 Tanzanian subtype C gp145 envelope protein for clinical development
22. P04-22. Multispecific monoclonal antibodies bind to primary human macrophages and induce the production of protective chemokines, MIP-1α and MIP-1β
23. P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays
24. P19-41. Full-length IMC expressing Renilla luciferase for neutralization assay using PBMC
25. P04-19. Analysis of the binding of multiple clades of HIV-1 by a modified virus capture assay
26. P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes
27. Expression of Human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection
28. Detection of submonolayer 18O on a gold surface by nuclear reaction analysis
29. Measurement of optical losses and damage thresholds of multilayer coatings
30. 'I Can Tell You It's a Bit of a Gamble': A Qualitative Analysis of How People Who Engage in Gaming and Gambling Understand a Link Between These Two Behaviours.
31. A crisis of exhaustion in the game of escalation: a qualitative exploration of the consequences of occupational burnout among addiction therapists.
32. Adaptation and validation of the Columbia-Suicide Severity Rating Scale (C-SSRS) - screen version.
33. Mobile application recovery support for patients with an alcohol use disorder. Acceptance, usability, and perceived helpfulness.
34. Motives for using new psychoactive substances in three groups of Polish users: nightlife, marginalised and active on the In.
35. Risk perception and risk aversion among people who use New Psychoactive Substances.
36. Negative consequences of novel psychoactive substances use among the Polish users.
37. Patients' and professionals' beliefs about the impact of social stigmatization on treatment of gambling-related disorders.
38. Psychometric properties of the Polish version of two screening tests for gambling disorders: the Problem Gambling Severity Index and Lie/Bet Questionnaire.
39. Why do people use new psychoactive substances? Development of a new measurement tool in six European countries.
40. Perceived social stigmatisation of gambling disorders and coping with stigma.
41. Screening of problem gambling among a homeless population in Warsaw.
42. What makes people with gambling disorder undergo treatment? Patient and professional perspectives.
43. Health and Social Problems Associated with Recent Novel Psychoactive Substance (NPS) Use Amongst Marginalised, Nightlife and Online Users in Six European Countries.
44. Barriers in Access to the Treatment for People with Gambling Disorders. Are They Different from Those Experienced by People with Alcohol and/or Drug Dependence?
45. Barriers in the access to alcohol treatment in outpatient clinics in urban and rural community.
46. Contextual determinants of alcohol consumption changes and preventive alcohol policies: a 12-country European study in progress.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.